The effect of dexmedetomidine on motor-evoked potentials during pediatric posterior spinal fusion surgery: a retrospective case-control study; [Effet de la dexmédétomidine sur les potentiels évoqués moteurs pendant une chirurgie de fusion spinale postérieure chez l’enfant : une étude cas témoins rétrospective]

被引:0
|
作者
Holt F. [1 ]
Strantzas S. [2 ]
Zaarour C. [1 ]
Chamlati R. [1 ]
Vreugdenhil I. [2 ]
Luginbuehl I. [1 ]
Karsli C. [1 ]
Faraoni D. [1 ]
机构
[1] Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, M5G 1X8, ON
[2] Department of Surgical Neuromonitoring, The Hospital for Sick Children, University of Toronto, Toronto, ON
来源
Canadian Journal of Anesthesia/Journal canadien d'anesthésie | 2020年 / 67卷 / 10期
关键词
Anesthesia intravenous; Dexmedetomidine; Evoked potentials; Neurophysiological monitoring; Spinal fusion;
D O I
10.1007/s12630-020-01758-6
中图分类号
学科分类号
摘要
Purpose: Motor-evoked potentials (MEPs) are frequently used in pediatric posterior spinal fusion surgery (PSFS) to detect spinal cord ischemia. Dexmedetomidine is increasingly being used as an adjunct to total intravenous anesthesia, but its effect on MEP amplitude has been variably reported. The purpose of this study was to evaluate the effect of an infusion of dexmedetomidine on the amplitude of MEPs. Methods: We performed a retrospective case-control study of 30 pediatric patients who received a 0.5 µg·kg−1·hr−1 infusion of dexmedetomidine, ten patients who received 0.3 µg·kg−1·hr−1 dexmedetomidine, and 30 control patients who did not receive dexmedetomidine during PSFS. Two neurophysiologists reviewed the MEP amplitudes in six muscle groups at three time points: when the patient was turned prone (baseline; T1), one hour after incision (T2), and after exposure of the spine but before insertion of the first screw (T3). Results: In all muscles tested, the mean MEP amplitude was reduced by T3 when dexmedetomidine was infused at 0.5 µg·kg−1·hr−1. The greatest reduction from baseline MEP amplitude was 829 µV (95% confidence interval, 352 to 1230; P < 0.001) seen in first right dorsus interosseous. When dexmedetomidine was infused at 0.3 µg·kg−1·hr−1, there was a significant reduction in MEP amplitude in four of the six muscles tested at T3 compared with the control group. Conclusions: Dexmedetomidine at commonly used infusion rates of 0.3 µg·kg−1·hr−1 or 0.5 µg·kg−1·hr−1 causes a significant decrease in MEP amplitude during pediatric PSFS. We suggest that dexmedetomidine should be avoided in children undergoing PSFS so as not to confuse the interpretation of this important neurophysiological monitor. © 2020, Canadian Anesthesiologists' Society.
引用
收藏
页码:1341 / 1348
页数:7
相关论文
共 2 条
  • [1] The effect of dexmedetomidine on motor-evoked potentials during pediatric posterior spinal fusion surgery: a retrospective case-control study
    Holt, Francesca
    Strantzas, Samuel
    Zaarour, Christian
    Chamlati, Racha
    Vreugdenhil, Ian
    Luginbuehl, Igor
    Karsli, Cengiz
    Faraoni, David
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2020, 67 (10): : 1341 - 1348
  • [2] Dosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study; [Posologie et efficacité de la sédation intranasale à base de dexmédétomidine pour l’échocardiographie transthoracique chez l’enfant: une étude rétrospective]
    Miller J.W.
    Divanovic A.A.
    Hossain M.M.
    Mahmoud M.A.
    Loepke A.W.
    Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2016, 63 (7): : 834 - 841